Aufrufe
vor 4 Monaten

bioplasticsMAGAZINE_1201

  • Text
  • Bioplastics
  • Materials
  • Plastics
  • Applications
  • Properties
  • Automotive
  • Products
  • Polymer
  • Germany
  • Processing
  • Www.bioplasticsmagazine.com
bioplasticsMAGAZINE_1201

Content Materials New

Content Materials New biobased plastic for technical applications ...... 24 Transparent packing material from birch .......... 31 Four-unit process technology for PLA manufacturing . 50 Application The biological bearing material ................... 27 Editorial ...................................3 News ......................................5 Application News ...........................40 Suppliers Guide ............................62 Event Calendar .............................65 Companies in this issue .....................66 NPE Show Preview .............................32 Show Guide ...............................36 01|2012 January/February Foam PHBV foams and its engineered composites ......... 28 Report BIOCORE – a biorefinery concept .................. 42 Successful start in Thailand ...................... 52 From Science & Research PLA nanocomposites ............................ 46 Basics Basics of PLA .................................. 54 Did you know ? Photovoltaic vs biofuels .......................... 58 Interview Pilar Echezarreta ............................... 60 Automotive BioConcept-Car .......................... 10 Fuel line made of bio-PA 1010 ............... 13 Bioplastics in automotive applications ......... 14 PLA and carbon nanotubes .................. 18 Automotive parts must be predictable ......... 20 Rubber from dandelions for tyres ............. 22 80% Bioplastic in Toyota SAI ................. 23 Imprint Publisher / Editorial Dr. Michael Thielen Samuel Brangenberg Layout/Production Mark Speckenbach, Julia Hunold Head Office Polymedia Publisher GmbH Dammer Str. 112 41066 Mönchengladbach, Germany phone: +49 (0)2161 6884469 fax: +49 (0)2161 6884468 info@bioplasticsmagazine.com www.bioplasticsmagazine.com Media Adviser Elke Hoffmann, Caroline Motyka phone: +49(0)2161-6884467 fax: +49(0)2161 6884468 eh@bioplasticsmagazine.com Print Tölkes Druck + Medien GmbH 47807 Krefeld, Germany Total Print run: 7,200 copies bioplastics magazine ISSN 1862-5258 bioplastics magazine is published 6 times a year. This publication is sent to qualified subscribers (149 Euro for 6 issues). bioplastics MAGAZINE is printed on chlorine-free FSC certified paper. bioplastics MAGAZINE is read in 91 countries. Not to be reproduced in any form without permission from the publisher. The fact that product names may not be identified in our editorial as trade marks is not an indication that such names are not registered trade marks. bioplastics MAGAZINE tries to use British spelling. However, in articles based on information from the USA, American spelling may also be used. Editorial contributions are always welcome. Please contact the editorial office via mt@bioplasticsmagazine.com. Envelopes A part of this print run is mailed to the readers wrapped in envelopes sponsored and produced by Minima Technologies Cover: Michael Thielen 4 bioplastics MAGAZINE [01/12] Vol. 7 Follow us on twitter: http://twitter.com/bioplasticsmag Be our fan on Facebook: http://www.facebook.com/pages/bioplastics-MAGAZINE/103745406344904

News Telles JV is ending – Mirel shall go on … Metabolix announced on Jan. 12, 2012 that ADM has given notice of termination of the Telles, LLC joint venture for PHA bioplastics. Metabolix however, will remain committed to successfully commercializing PHA bioplastics, as Richard Eno, Chief Executive Officer of Metabolix points out. The effective date of the termination will be February 8, 2012. Telles was established as a joint venture between Metabolix, Cambridge, Massachussetts, USA, and ADM, Decatur, Illinois, USA in July 2006. The joint venture sold PHA-based bioplastics, including Mirel and Mvera, in the USA, Europe and other countries. All Metabolix technology concerning PHA bioplastics that was used in the joint venture, including intellectual property rights, will revert solely to Metabolix. “Clearly, we are disappointed by ADM’s decision to withdraw from Telles. While this is a setback, we remain committed to successfully commercializing PHA bioplastics. Over the past few years, we now have proven the technology at industrial scale and believe that we now have the opportunity to launch this business with a different business model,” said Richard Eno. He continued, “We sincerely thank our customers, distributors, and partners for their interest in developing PHA-based solutions to address a growing market need for bioplastics. We will be evaluating alternate plans for commercialization and clearly wish to supply this growing market in the future.” Being asked by bioplastics MAGAZINE how such alternate plans could look like, Richard Eno responded:” Given Metabolix’s PHA intellectual property technology portfolio and longtime experience within the industry, we’re confident that we’ll be successful in finding a new option for manufacturing and commercialization. The Company has been in contact with potential partners who expressed interest – these include raw materials suppliers, manufacturers, industry players and customers. Metabolix will continue to engage in new partnering discussions and evaluate options to launch its PHA bioplastics business with a new model.” And he added: “The bioplastics market is growing at 20 percent per year, and based on our experience, we can see where a PHA offering can participate in this growth – as is evidenced by the strong customer validation we’ve had for the product. Metabolix’s PHA technology platform is a valuable contribution to the industry, and as such, the Company plans to continue to focus on the development of PHA bioplastics. Metabolix is also developing biosourced industrial chemicals and a proprietary platform technology for co-producing plastics, chemicals and energy, from crops. We believe that Metabolix is positioned for growth, as the demand for biobased technologies continues to rise.” And finally, Eno is keen to: “... express my appreciation for the efforts put forth by the Telles and ADM Polymer teams, who have demonstrated the commercialization of PHA bioplastics at world scale. MT www.metabolix.com Richard Eno, CEO, Metabolix Rodenburg acquired Optimum Rodenburg Biopolymers BV, Oosterhout, the Netherlands, manufacturer of potato starch based Solanyl bioplastic compounds, has purchased Optimum BV, Rotterdam, the Netherlands, producer of FlourPlast biodegradable biopolymers. Details about the financial terms of the deal were not disclosed. Both products, Solanyl and FlourPlast, were developed with the German company Wacker Chemie from Munich. The acquisition enables Rodenburg to serve both the converter and the compounder markets with biopolymers. The raw materials for their Solanyl compound are based on reclaimed side stream starch from the potato processing industry. This is now complemented by Optimum’s proprietary FlourPlast biopolymer, based on grain-derived products, which can be directly compounded with existing biopolyesters. In addition, FlourPlast allows processors to fine-tune bioplastic or polyolefin formulations to achieve desired properties and reduce costs. Solanyl, available since 2004 can be used in injection moulding, sheet extrusion, thermoforming and blow moulding. It is sold as a compound, where as FlourPlast is sold as a pre-compound system. MT www.biopolymers.nl www.optimumbioplastics.com bioplastics MAGAZINE [01/12] Vol. 7 5

bioplastics MAGAZINE ePaper